HIRONC

Seoul, South Korea – October 18, 2025 – HIRONIC Co., Ltd., a global leader in aesthetic and medical device innovation, announced the successful conclusion of its “SYNERJET X K BOOSTER Masterclass Seminar,” held on October 18.

Led by Dr. Sangsoo Lee (Mirabel Clinic) and Dr. Sanghyuk Kim (Grandmedi Clinic), the event showcased best practices in delivering tailored solutions using HIRONIC’s needle-free microjet device SYNERJET in combination with K BOOSTER, a high-functionality aesthetic derma brand. The speakers shared clinical know-how based on real-world applications and synergy-driven outcomes.

A key highlight of the seminar was the “K BOOSTER SHOWER” protocol—a needle-free, painless absorption method that uses SYNERJET to deliver K BOOSTER PDRN Plus Ampoule deep into the skin. This next-generation skin booster solution drew significant attention from attending medical professionals for its effectiveness and patient comfort.

Developed by HIRONIC, SYNERJET is designed to deliver active ingredients through microjet spray technology without the use of needles. Its compatibility with a wide range of skin booster formulations makes it a versatile device for various clinical applications, enhancing both practitioner convenience and patient satisfaction.

K BOOSTER, known for its ECM (extracellular matrix)-based active ingredients, has gained strong traction across dermatology clinics and the home care market. When paired with SYNERJET, the ampoules demonstrate enhanced absorption rates and user satisfaction.

“This seminar was more than a product demonstration—it was an opportunity to validate a comprehensive solution that benefits both practitioners and patients,” said a HIRONIC spokesperson. “We will continue to build new standards in aesthetic medicine by expanding collaborations centered around SYNERJET.”

The event also included live device demonstrations and hands-on sessions, helping attendees gain practical insights into skin and scalp care techniques.

HIRONIC continues to lead in the aesthetic medical field by combining innovation and clinical collaboration. The company aims to foster global growth through advanced technologies and strategic partnerships.​